Effect of <i>MYCN</i> Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma. [PDF]
Matser YAH +12 more
europepmc +1 more source
KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway. [PDF]
Lyu Q +10 more
europepmc +1 more source
Detection of Tumor Suppressor Genes Rare Variants: Findings From Neuroblastoma Using Next-Generation Sequencing. [PDF]
Erol A +4 more
europepmc +1 more source
CCL2: A double-edged sword in neuroblastoma, with a critical role in MYCN-amplified tumors. [PDF]
Jannot L +4 more
europepmc +1 more source
Antidepressant-like effects of Rg1 by mycn: promotion of neurogenesis in the hippocampus. [PDF]
Shi E +5 more
europepmc +1 more source
Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities. [PDF]
Gupta R +8 more
europepmc +1 more source
Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastoma. [PDF]
Xie W +10 more
europepmc +1 more source
Advances in multi-omics research on neuroblastoma. [PDF]
Wang Y +6 more
europepmc +1 more source
Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis. [PDF]
Qin XY +25 more
europepmc +1 more source
Single-cell and spatial omics reveals region-specific plasticity and therapeutic vulnerabilities in metastatic high-risk neuroblastoma. [PDF]
Wu LMN +11 more
europepmc +1 more source

